2-pyrimidinyl pyrazolopyridine ErbB kinase inhibitors
US7812022B2 · kind B2 · utility
5Cited by
6References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 6, 2005 |
| Grant date | Oct 12, 2010 |
| Priority date | — |
| Expiry date | Jan 20, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides 2-pyrimidinyl pyrazolopyridine compounds, compositions containing the same, as well as processes for the preparation and their use as pharmaceutical agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.